NEUROONE MEDICAL TECHNOLOGIES Corp Financial Ratios
NMTC|FY2025 SEC 10-K data
Includes DuPont ROE decomposition, profitability margins, liquidity ratios, solvency indicators, and earnings quality analysis. All ratios calculated from FY2025 SEC 10-K data.
Key Data Points
- Altman Z-Score -2.54 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
DuPont ROE Decomposition (FY2025)
Return on Equity
-1498.5%
Profit Margin
-356.7%
Net Income / Revenue
Asset Turnover
0.32
Revenue / Total Assets
Equity Multiplier
13.12
Total Assets / Equity
Composite: -1498.5% (reported: -1498.5%)
Profitability
Liquidity
Current Ratio
4.44
Quick Ratio
3.47
Solvency
Interest Coverage
-
Efficiency
Asset Turnover
0.32
Inventory Turnover
1.07
Days Sales Outstanding
134 days
As of FY2025 · SEC 10-K · Updated Jun 28, 2026
Earnings Quality
Accrual Ratio
-16.2%
-35.3pp YoY
Earnings are primarily supported by operating cash flow.
This metric is for informational purposes only and does not constitute investment advice. Data sourced from SEC EDGAR filings; updates may be delayed.